• Investor Home
  • Apollo Endosurgery to Present at the 29th Annual Piper Jaffray Healthcare Conference

Apollo Endosurgery to Present at the 29th Annual Piper Jaffray Healthcare Conference

Friday, November 17, 2017 3:01 pm CST

Public Company Information:

NASDAQ:
APEN

AUSTIN, Texas--(BUSINESS WIRE)--Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a leader in less invasive medical devices for bariatric and gastrointestinal procedures, announced today that Company management is scheduled to present at the 29th Annual Piper Jaffray Healthcare Conference on November 28, 2017 at 8:50 am ET in New York, NY.

An audio webcast of the Company’s presentation will be available online at ir.apolloendo.com and will be available for replay for 90 days.

Investors attending the conference who would like to schedule a one-on-one meeting with Apollo management may do so by contacting their Piper Jaffray representative, or Lee Roth or Zack Kubow of The Ruth Group at apolloendo@theruthgroup.com.

About Apollo Endosurgery, Inc.

Apollo Endosurgery, Inc. is a medical device company focused on less invasive therapies for the treatment of obesity, a condition facing over 600 million people globally, as well as other gastrointestinal disorders. Apollo’s device based therapies are an alternative to invasive surgical procedures, thus lowering complication rates and reducing total healthcare costs. Apollo's products are offered in over 80 countries today.

Apollo’s common stock is traded on NASDAQ Global Market under the symbol "APEN". For more information regarding Apollo Endosurgery, go to: www.apolloendo.com.

Contact:

Apollo Endosurgery, Inc.
Stefanie Cavanaugh, 512-279-5100
Chief Financial Officer
investor-relations@apolloendo.com
or
The Ruth Group
Lee Roth or Zack Kubow, 646-536-7000
apolloendo@theruthgroup.com

Business Wire InvestorHQ℠